Nanoparticle-mediated hyperthermia in cancer therapy

Therapeutic Delivery

Volumn 2, Issue 8, 2011, Pages 1001-1014

  Chatterjee, Dev Kumar ^a   Diagaradjane, Parmeswaran ^a   Krishnan, Sunil ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON NANOTUBE; GOLD NANOPARTICLE; GOLD NANOROD; GOLD NANOSHELL; MULTI WALLED NANOTUBE; NANOPARTICLE; SINGLE WALLED NANOTUBE; SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG;

ARTICLE; BIOCOMPATIBILITY; CANCER CELL DESTRUCTION; CANCER RADIOTHERAPY; CANCER STEM CELL; CANCER THERAPY; CARDIOVASCULAR DISEASE; DIARRHEA; ELECTROMAGNETIC RADIATION; GASTROINTESTINAL SYMPTOM; HEAD AND NECK CANCER; HEART FAILURE; HEART MUSCLE ISCHEMIA; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; HYPERTHERMIC THERAPY; MAGNETIC FIELD; MAGNETISM; MESOTHELIOMA; NAUSEA AND VOMITING; NONHUMAN; PERITONEUM CANCER; PRIORITY JOURNAL; PROSTATE CANCER; REGIONAL HYPERTHERMIA; SUBCUTANEOUS TISSUE TUMOR; THERANOSTICS; THERMOABLATION; THROMBOSIS; TUMOR ABLATION; TUMOR NECROSIS; VASCULAR FOCUSED HYPERTHERMIA; WHOLE BODY HYPERTHERMIA;

EID: 80052408037     PISSN: 20415990     EISSN: 20416008     Source Type: Journal    
DOI: 10.4155/tde.11.72     Document Type: Article

References (71)

1. Coley WB. II. Contribution to the Knowledge of Sarcoma. Ann. Surg. 14(3), 199-220 (1891).
2. Friedenthal E, Mendecki J, Botstein C, Sterzer F, Nowogrodzki M, Paglione R. Some practical considerations for the use of localized hyperthermia in the treatment of cancer. J. Microw. Power 16(2), 199-204 (1981). (Pubitemid 12556340)
3. Lele PP. Induction of deep, local hyperthermia by ultrasound and electromagnetic felds: problems and choices. Radiat. Environ. Biophys. 17(3), 205-217 (1980). (Pubitemid 10153661)
4. Magin RL, Johnson RK. Effects of local tumor hyperthermia on the growth of solid mouse tumors. Cancer Res. 39(11), 4534-4539 (1979). (Pubitemid 10197617)
5. Kim JH, Hahn EW, Ahmed SA. Combination hyperthermia and radiation therapy for malignant melanoma. Cancer 50(3), 478-482 (1982). (Pubitemid 12097416)
6. Luk KH, Francis ME, Perez CA, Johnson RJ. Combined radiation and hyperthermia: comparison of two treatment schedules based on data from a registry established by the Radiation Therapy Oncology Group (RTOG). Int. J. Radiat. Oncol. Biol. Phys. 10(6), 801-809 (1984). (Pubitemid 14094056)
7. Stewart JR, Gibbs FA Jr. Hyperthermia in the treatment of cancer. Perspectives on its promise and its problems. Cancer 54(11 Suppl.), 2823-2830 (1984). (Pubitemid 15187423)
8. Thrall DE. Clinical requirements for localized hyperthermia in the patient. Radiat. Environ. Biophys. 17(3), 229-232 (1980).
9. Doss JD, Mccabe CW. A technique for localized heating in tissue: an adjunct to tumor therapy. Med. Instrum. 10(1), 16-21 (1976).
10. Irish CE, Brown J, Galen WP et al. Thermoradiotherapy for persistent cancer in previously irradiated felds. Cancer 57(12), 2275-2279 (1986). (Pubitemid 16118963)
11. Seegenschmiedt MH, Sauer R, Miyamoto C, Chalal JA, Brady LW. Clinical experience with interstitial thermoradiotherapy for localized implantable pelvic tumors. Am. J. Clin. Oncol. 16(3), 210-222 (1993). (Pubitemid 23184383)
12. Bass H, Moore JL, Coakley WT. Lethality in mammalian cells due to hyperthermia under oxic and hypoxic conditions. Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 33(1), 57-67 (1978). (Pubitemid 8256035)
13. Storm FK. Clinical hyperthermia and chemotherapy. Radiol. Clin. North Am. 27(3), 621-627 (1989).
14. Urano M, Kuroda M, Nishimura Y. For the clinical application of thermochemotherapy given at mild temperatures. Int. J. Hyperthermia 15(2), 79-107 (1999). (Pubitemid 29149801)
15. Shakil A, Osborn JL, Song C W. Changes in oxygenation status and blood fow in a rat tumor model by mild temperature hyperthermia. Int. J. Radiat. Oncol. Biol. Phys. 43(4), 859-865 (1999). (Pubitemid 29152659)
16. Johannsen M, Thiesen B, Wust P, Jordan A. Magnetic nanoparticle hyperthermia for prostate cancer. Int. J. Hyperthermia 26(8), 790-795 (2010).
17. Hurwitz MD, Hansen JL, Prokopios-Davos S et al. Hyperthermia combined with radiation for the treatment of locally advanced prostate cancer: long-term results from Dana-Farber Cancer Institute study 94-153. Cancer 117(3), 510-516 (2011).
18. Moros EG, Penagaricano J, Novak P, Straube WL, Myerson RJ. Present and future technology for simultaneous superfcial thermoradiotherapy of breast cancer. Int. J. Hyperthermia 26(7), 699-709 (2010)
19. Van Den Berg CA, Van De Kamer JB, De Leeuw AA et al. Towards patient specifc thermal modelling of the prostate. Phys. Med. Biol. 51(4), 809-825 (2006).
20. Zagar TM, Oleson JR, Vujaskovic Z et al. Hyperthermia combined with radiation therapy for superfcial breast cancer and chest wall recurrence: a review of the randomised data. Int. J. Hyperthermia 26(7), 612-617 (2010).
21. Franckena M, Van Der Zee J. Use of combined radiation and hyperthermia for gynecological cancer. Curr. Opin. Obstet. Gynecol. 22(1), 9-14 (2010).
22. Vasanthan A, Mitsumori M, Park JH et al. Regional hyperthermia combined with radiotherapy for uterine cervical cancers: a multi-institutional prospective randomized trial of the international atomic energy agency. Int. J. Radiat. Oncol. Biol. Phys. 61(1), 145-153 (2005). (Pubitemid 40039116)
23. Huilgol NG, Gupta S, Sridhar CR. Hyperthermia with radiation in the treatment of locally advanced head and neck cancer: a report of randomized trial. J. Cancer Res. Ther. 6(4), 492-496 (2010).
24. Huilgol NG, Gupta S, Dixit R. Chemoradiation with hyperthermia in the treatment of head and neck cancer. Int. J. Hyperthermia 26(1), 21-25 (2010).
25. Chang E, Alexander HR, Libutti SK et al. Laparoscopic continuous hyperthermic peritoneal perfusion. J. Am. Coll. Surg. 193(2), 225-229 (2001). (Pubitemid 32729627)
26. Feldman AL, Libutti SK, Pingpank JF et al. Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy. J. Clin. Oncol. 21(24), 4560-4567 (2003). (Pubitemid 46594027)
27. Maeda H. The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Adv. Enzyme Regul. 41, 189-207 (2001).
28. Maeda H, Wu J, Sawa T, Matsumura Y, Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J. Control. Release 65(1-2), 271-284 (2000). (Pubitemid 30122932)
29. Kah JC, Wong KY, Neoh KG et al. Critical parameters in the pegylation of gold nanoshells for biomedical applications: an in vitro macrophage study. J. Drug Target 17(3), 181-193 (2009).
30. Wang J, Sui M, Fan W. Nanoparticles for tumor targeted therapies and their pharmacokinetics. Curr. Drug Metab. 11(2), 129-141 (2010).
31. El-Sayed IH, Huang X, El-Sayed MA. Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles. Cancer Lett. 239(1), 129-135 (2006). (Pubitemid 43946581)
32. Waldman SA, Fortina P, Surrey S, Hyslop T, Kricka LJ, Graves DJ. Opportunities for near-infrared thermal ablation of colorectal metastases by guanylyl cyclase C-targeted gold nanoshells. Future Oncol. 2(6), 705-716 (2006). (Pubitemid 44941988)
33. Patra CR, Bhattacharya R, Mukhopadhyay D, Mukherjee P. Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer. Adv. Drug Deliv. Rev. 62(3), 346-361 (2010).
34. Hosta-Rigau L, Olmedo I, Arbiol J, Cruz LJ, Kogan MJ, Albericio F. Multifunctionalized gold nanoparticles with peptides targeted to gastrin-releasing peptide receptor of a tumor cell line. Bioconjug. Chem. 21(6), 1070-1078 (2010).
35. Diagaradjane P, Shetty A, Wang JC et al. Modulation of in vivo tumor radiation response via gold nanoshell-mediated vascular-focused hyperthermia: characterizing an integrated antihypoxic and localized vascular disrupting targeting strategy. Nano Lett. 8(5), 1492-1500 (2008).
36. Hirsch LR, Gobin AM, Lowery AR et al. Metal nanoshells. Ann. Biomed. Eng. 34(1), 15-22 (2006).
37. Hulander M, Hong J, Andersson M et al. Blood interactions with noble metals: coagulation and immune complement activation. ACS Appl. Mater. Interfaces 1(5), 1053-1062 (2009).
38. Choi WI, Kim JY, Kang C, Byeon CC, Kim YH, Tae G. Tumor regression in vivo by photothermal therapy based on gold-nanorod-loaded, functional nanocarriers. ACS Nano 5(3), 1995-2003 (2011).
39. Von Maltzahn G, Park JH, Agrawal A et al. Computationally guided photothermal tumor therapy using long-circulating gold nanorod antennas. Cancer Res. 69(9), 3892-3900 (2009).
40. Hirsch LR, Stafford RJ, Bankson JA et al. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc. Natl Acad. Sci. USA 100(23), 13549-13554 (2003). (Pubitemid 37444779)
41. O'neal DP, Hirsch LR, Halas NJ, Payne JD, West JL. Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles. Cancer Lett. 209(2), 171-176 (2004). (Pubitemid 38670486)
42. Bernardi RJ, Lowery AR, Thompson PA, Blaney SM, West JL. Immunonanoshells for targeted photothermal ablation in medulloblastoma and glioma: an in vitro evaluation using human cell lines. J. Neurooncol. 86(2), 165-172 (2008). (Pubitemid 350263413)
43. Cheng FY, Chen CT, Yeh CS. Comparative effciencies of photothermal destruction of malignant cells using antibody-coated silica-Au nanoshells, hollow Au/Ag nanospheres and Au nanorods. Nanotechnology 20(42), 425104 (2009).
44. Dickerson EB, Dreaden EC, Huang X et al. Gold nanorod assisted near-infrared plasmonic photothermal therapy (PPTT) of squamous cell carcinoma in mice. Cancer Lett. 269(1), 57-66 (2008).
45. Skrabalak SE, Au L, Lu X, Li X, Xia Y. Gold nanocages for cancer detection and treatment. Nanomedicine (Lond.) 2(5), 657-668 (2007). (Pubitemid 350268245)
46. Atkinson RL, Zhang M, Diagaradjane P et al. Thermal enhancement with optically activated gold nanoshells sensitizes breast cancer stem cells to radiation therapy. Sci. Transl. Med. 2(55), 55ra79 (2010).
47. Gilchrist RK, Medal R, Shorey WD, Hanselman RC, Parrott JC, Taylor CB. Selective inductive heating of lymph nodes. Ann. Surg. 146(4), 596-606 (1957).
48. Yallapu MM, Othman SF, Curtis ET, Gupta BK, Jaggi M, Chauhan SC. Multifunctional magnetic nanoparticles for magnetic resonance imaging and cancer therapy. Biomaterials 32(7), 1890-1905 (2011).
49. Huang N, Wang H, Zhao J, Lui H, Korbelik M, Zeng H. Single-wall carbon nanotubes assisted photothermal cancer therapy: animal study with a murine model of squamous cell carcinoma. Lasers Surg. Med. 42(9), 638-648
50. Elsherbini AA, Saber M, Aggag M, El-Shahawy A, Shokier HA. Magnetic nanoparticle-induced hyperthermia treatment under magnetic resonance imaging. Magn. Reson. Imaging 29(2), 272-280 (2011).
51. Majumdar S, Zoghbi SS, Gore JC. Pharmacokinetics of superparamagnetic iron-oxide MR contrast agents in the rat. Invest. Radiol. 25(7), 771-777 (1990). (Pubitemid 20202573)
52. Okon E, Pouliquen D, Okon P et al. Biodegradation of magnetite dextran nanoparticles in the rat. A histologic and biophysical study. Lab. Invest. 71(6), 895-903 (1994).
53. Wu X, Tan Y, Mao H, Zhang M. Toxic effects of iron oxide nanoparticles on human umbilical vein endothelial cells. Int. J. Nanomedicine 5, 385-399 (2010).
54. Fan C, Gao W, Chen Z et al. Tumor selectivity of stealth multi-functionalized superparamagnetic iron oxide nanoparticles. Int. J. Pharm. 404(1-2), 180-190 (2011).
55. Balivada S, Rachakatla RS, Wang H et al. A/C magnetic hyperthermia of melanoma mediated by iron(0)/iron oxide core/shell magnetic nanoparticles: a mouse study. BMC Cancer 10, 119 (2010).
56. Rachakatla RS, Balivada S, Seo GM et al. Attenuation of mouse melanoma by A/C magnetic feld after delivery of bi-magnetic nanoparticles by neural progenitor cells. ACS Nano 4(12), 7093-7104 (2010).
57. Le Renard PE, Jordan O, Faes A et al. The in vivo performance of magnetic particle-loaded injectable, in situ gelling, carriers for the delivery of local hyperthermia. Biomaterials 31(4), 691-705 (2010).
58. Hayashi K, Ono K, Suzuki H et al. High-frequency, magnetic-feld- responsive drug release from magnetic nanoparticle/organic hybrid based on hyperthermic effect. ACS Appl. Mater. Interfaces 2(7), 1903-1911 (2010).
59. Mohammad F, Balaji G, Weber A, Uppu RM, Kumar CS. Infuence of gold nanoshell on hyperthermia of superparamagnetic iron oxide nanoparticles (SPIONs). J. Phys. Chem. C Nanomater. Interfaces 1(20), 3141-3146 (2010).
60. Zheng LX, O'connell MJ, Doorn SK et al. Ultralong single-wall carbon nanotubes. Nat. Mater. 3(10), 673-676 (2004).
61. Kam NW, O'Connell M, Wisdom JA, Dai H. Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction. Proc. Natl Acad. Sci. USA 102(33), 11600-11605 (2005). (Pubitemid 41170772)
62. Biris AS, Boldor D, Palmer J et al. Nanophotothermolysis of multiple scattered cancer cells with carbon nanotubes guided by time-resolved infrared thermal imaging. J. Biomed. Opt. 14(2), 021007 (2009).
63. Torti SV, Byrne F, Whelan O et al. Thermal ablation therapeutics based on CN(x) multi-walled nanotubes. Int. J. Nanomedicine 2(4), 707-714 (2007).
64. Moon HK, Lee SH, Choi HC. In vivo near-infrared mediated tumor destruction by photothermal effect of carbon nanotubes. ACS Nano 3(11), 3707-3713 (2009).
65. Gannon CJ, Cherukuri P, Yakobson BI et al. Carbon nanotube-enhanced thermal destruction of cancer cells in a noninvasive radiofrequency feld. Cancer 110(12), 2654-2665 (2007). (Pubitemid 350250334)
66. Burke A, Ding X, Singh R et al. Long-term survival following a single treatment of kidney tumors with multiwalled carbon nanotubes and near-infrared radiation. Proc. Natl Acad. Sci. USA 106(31), 12897-12902 (2009).
67. Poland CA, Duffn R, Kinloch I et al. Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nat. Nanotechnol. 3(7), 423-428 (2008).
68. Glazer ES, Curley SA. Radiofrequency feld-induced thermal cytotoxicity in cancer cells treated with fuorescent nanoparticles. Cancer 116(13), 3285-3293 (2010).
69. Melnikov OV, Gorbenko OY, Markelova MN et al. Ag-doped manganite nanoparticles: new materials for temperature-controlled medical hyperthermia. J. Biomed. Mater. Res. A 91(4), 1048-1055 (2009).
70. Fuller KJ, Issels RD, Slosman DO, Guillet JG, Soussi T, Polla BS. Cancer and the heat-shock response. Eur. J. Cancer 30A(12), 1884-1891 (1994).
71. Harmon BV, Takano YS, Winterford CM, Gobe GC. The role of apoptosis in the response of cells and tumours to mild hyperthermia. Int. J. Radiat. Biol. 59(2), 489-501 (1991).